NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.
The stock closed at $35.95 on Friday.
Must Read: Warren Buffett's 25 Favorite Stocks
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts